Skip to main content

Enzamaría Fidilio Meli

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Enzamaría Fidilio Meli

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

¿CONOCER LA PREDISPOSICIÓN GENETICA DEL PACIENTE CON OBESIDAD AYUDA A MEJORAR LA EFICACIA DE LA CIRUGÍA BARIÁTRICA?

IP: Albert Lecube Torelló
Collaborators: Marta Comas Martinez, Enzamaría Fidilio Meli
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI21/00462
Duration: 01/01/2022 - 30/06/2026

ROL DE LA APELINA EN LA ENFERMEDAD RENAL DIABÉTICA: DEL RATÓN AL HUMANO

IP: Maria Jose Soler Romeo
Collaborators: Sara Nuñez Delgado, Marina Lopez Martinez, Jordi Vilardell Vila, Irene Martinez Diaz, Sheila Bermejo Garcia, Vicent Muñoz Vaño, Carmen Llorens Cebriá, M Antonieta Azancot Rivero, Enzamaría Fidilio Meli, Juan Carlos León Román
Funding agency: Instituto de Salud Carlos III
Funding: 190000
Reference: PI24/01510
Duration: 01/01/2025 - 31/12/2027

Utilidad del TAC abdominal e inteligencia artificial para la evaluación de la composición corporal y condición metabólica en sujetos con obesidad: estudio FLASH

IP: Andreea Ciudin Mihai
Collaborators: Lucia Iglesias Sanchez, Manuel Escobar Amores, Nuria Roson Gradaille, Fiorella Ximena Palmas Candia, Aitor Rodriguez Martinez, Marta Comas Martinez, Enzamaría Fidilio Meli
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 431460
Reference: CPP2023-010524
Duration: 01/11/2024 - 30/10/2027

Ministerio de Ciencia

Utilidad del TAC abdominal e inteligencia artificial para la evaluación de la composición corporal y condición metabólica en sujetos con obesidad: estudio FLASH

IP: Andreea Ciudin Mihai
Collaborators: Manuel Escobar Amores, Nuria Roson Gradaille, Fiorella Ximena Palmas Candia, Aitor Rodriguez Martinez, Marta Comas Martinez, Enzamaría Fidilio Meli
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 431460
Reference: CPP2023-010524
Duration: 01/11/2024 - 30/10/2027

Ministerio de Ciencia

Related news

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.

The study evaluates elecoglipron and shows improvements in glycemic control and body weight compared with placebo.

Related professionals

Alfonso Biarnes Suñe

Alfonso Biarnes Suñe

Senior researcher
Reconstructive Surgery of the Locomotor System
Read more
Sebastian Viale Romero

Sebastian Viale Romero

Senior researcher
Cardiovascular Diseases
Read more
Esther Tur Escandell

Esther Tur Escandell

Predoctoral researcher
Pharmacokinetic Nanoparticles
Read more
Pau Gimeno Tio

Pau Gimeno Tio

Senior researcher
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.